#603: Should Dietary Fiber Be Considered Essential? – Andrew Reynolds, PhD

Dietary fiber is widely recognized as an important component of a healthy diet, yet it is not typically classified as an essential nutrient. In this episode, Dr. Andrew Reynolds explores whether that distinction still holds, arguing that the traditional criteria used to define essentiality may be outdated when applied to modern nutrition science. The discussion moves beyond simply acknowledging the benefits of fiber and instead examines whether it meets the foundational requirements of an essential nutrient. This includes considering its physiological roles, the body's inability to synthesize it in sufficient quantities, and whether low intake leads to a meaningful and reversible dysfunction. Drawing on evidence from prospective cohort studies, randomized controlled trials, and mechanistic research, Reynolds outlines the strength of the evidence linking higher fiber intakes to reduced risk of cardiovascular disease, type 2 diabetes, colorectal cancer, and premature mortality.  Reynolds presents a compelling case that fiber may play a fundamental role in maintaining normal physiological function and therefore warrants reconsideration within the framework of essential nutrients. Timestamps: [03:50] Interview starts [05:53] Understanding essentiality [09:26] Could there be a deficiency-state for fiber? [15:38] What are fiber guidelines based on? [23:52] Fiber and chronic disease risk: dose-response [28:59] Different types of fiber [37:21] Fermentation and SCFAs [42:55] Research priorities ahead [50:04] Low fiber health risks [58:02] Key Ideas segment (Premium-only) Related Resources: Go to episode page Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Reynolds et al., 2026 – Dietary fibre as an essential nutrient: Reynolds et al., 2019 – Carbohydrate quality and human health: a series of systematic reviews and meta-analyses Episode 482: Carbohydrate Quality & Health – Andrew Reynolds, PhD

Avoidant/Restrictive Food Intake Disorder (ARFID) is an eating disorder diagnosis characterized by a persistent restriction or avoidance of food intake that results in clinically significant consequences (medical, nutritional, and/or psychosocial), but without the weight- and shape-driven psychopathology typical of anorexia nervosa and bulimia nervosa. In this episode, Megan Hellner and Katherine Hill outline how ARFID presents across the lifespan, why it is frequently missed in routine healthcare, and what an evidence-informed assessment and treatment pathway can look like in practice. A central theme is that ARFID is not synonymous with "picky eating" and not confined to any one body size. Patients may present at any point on the weight chart, including those who are weight-stable or in larger bodies, and the condition can begin in early childhood and persist into adulthood. The episode also highlights ARFID in athletes and physically active people, where restricted dietary variety and/or low intake can contribute to low energy availability and RED-S-like presentations, sometimes without an obvious intent to lose weight. Timestamps [03:48] Interview start [06:23] What is ARFID? DSM-5 definition vs "picky eating" [09:36] Clinical red flags: when restriction becomes a disorder [11:37] ARFID isn't always underweight: missed cases & diagnostic pitfalls [16:46] ARFID presentation profiles: low interest, sensory sensitivity, fear [18:59] Comorbidities & nutrition consequences [25:16] Evidence-based ARFID treatment [29:16] How to expand foods without pressure [32:28] Weight restoration, stabilization, and long-term maintenance [35:44] What research still needs [38:16] Differential diagnosis & referral Links/Resources Go to episode page (with links to papers and ARFID resources) Subscribe to Sigma Nutrition Premium Join the Sigma email newsletter for free Enroll in the next cohort of our Applied Nutrition Literacy course

This episode examines what we actually know (and importantly, what we do not know) about diet in relation to gallstones and gallbladder conditions. Much of the public-facing guidance around gallstones focuses on "avoiding fatty foods", yet Dr. Angela Madden explains that this long-standing practice sits on surprisingly weak direct evidence, particularly when judged against the standards typically expected for clinical dietary recommendations. A central theme is the need to separate two distinct questions: dietary factors that influence the risk of developing gallstones (prevention), versus dietary strategies intended to reduce symptoms or complications once gallstones exist (management). While the prevention literature suggests plausible, consistent associations with overall diet quality and lifestyle factors, the specific question of prescribing a low-fat diet to manage symptomatic gallstones lacks robust randomized trial evidence. Dr Angela Madden is a clinical researcher in nutrition and dietetics at the University of Hertfordshire, where she established and led the nutrition and dietetics subject group and now focuses her research on improving nutritional assessment, dietary interventions, and patient-centred outcomes in clinical and public health settings. Timestamps [02:09] Discussion with Dr. Angela Madden begins [06:53] Understanding the gallbladder [08:08] Gallbladder disorders and their prevalence [13:42] Risk factors and pathophysiology [22:15] Dietary factors and gallstone formation [27:20] Exploring dietary fat and gallstones [34:09] Broader dietary considerations [45:44] Practical dietary recommendations Related Resources Go to episode page Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Dr. Madden's univeristy page Cochrane Review: Madden et al., 2024 – Modified dietary fat intake for treatment of gallstone disease in people of any age Related episode: 513: Kidney Stones & Diet – Deepa Kariyawasam, RD

In this episode, Danny answers questions submitted by Premium subscribers. Questions Answered in This Episode: [00:05:13] Is eating too early (relative to chronotype) metabolically problematic? [00:16:55] Can plant-based diets reverse cardiovascular disease? [00:32:54] Are multivitamins useful insurance, or a waste with a good diet? [00:44:56] Does coevolution with foods determine human compatibility and benefit? [00:56:25] How should consumers choose supplement formulations and brands? [01:04:46] Folate vs folic acid: differences and best choice for women of childbearing age? [01:12:37] How reliable is omega-3 content in farmed salmon, especially imported frozen salmon? [01:19:18] How accurate are food labels for metabolizable energy and absorption, especially across processing levels? [01:23:58] Protein needs in breastfeeding and general rehabilitation (non-sport injury)? To listen to the full episode, subscribe to Sigma Nutrition Premium. Related Resources Go to episode page (with full resource list) Subscribe to Sigma Nutrition Premium Resources for this episode: Eckel et al., 2015 – Morning Circadian Misalignment during Short Sleep Duration Impacts Insulin Sensitivity Stothard et al., 2020 – Early Morning Food Intake as a Risk Factor for Metabolic Dysregulation Ep. #470: Melatonin, Meal Timing & Glucose Tolerance Ep. #579: Is Your Chronotype Hard-Wired or Modifiable? Article: A Plant Based Diet Reverses Heart Disease: True or False?

"The more we learn about the world, and the deeper our learning, the more conscious, specific, and articulate will be our knowledge of what we do not know, our knowledge of our ignorance. For this, indeed, is the main source of our ignorance — the fact that our knowledge can be only finite, while our ignorance must necessarily be infinite." – Karl Popper To mark Sigma Nutrition's milestone 600th episode (and 12-year anniversary), Danny and Alan examine several areas in which their views have changed, softened, strengthened, or remained stable over the lifespan of the podcast. The discussion is therefore not only about nutrition itself, but also about the process of scientific reasoning: how positions are formed, what type of evidence can shift them, and why changing one's mind is often a sign of better thinking rather than inconsistency. The episode therefore serves as both a review of several specific nutrition controversies and a lesson in scientific epistemology. They discuss topics such as red meat, protein, dietary cholesterol, omega-3s, flavonoids, and sodium. Timestamps [11:04] Time-restricted eating [19:32] Protein intake, quality & dosing [35:04] Cocoa flavanols and cognition [51:38] Unprocessed red meat [01:05:23] Omega-3 supplementation [01:23:10] Dietary cholesterol [01:44:41] Sodium J-curve myth [01:53:41] Energy balance model Links Go to episode page (with study links & resources) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course

This episode examines whether unprocessed red meat has a causal role in (1) type 2 diabetes risk and intermediate measures of glucose intolerance (insulin resistance, beta cell dysfunction, glycemic markers) and (2) cardiovascular disease (CVD) risk. While there is commonly observed risk signal from observational cohorts, there exist short-term randomized controlled trials (RCTs) that show largely null effects on glucose homeostasis. This had led to differing opinions and interpretations of the evidence base. Some feel that in the context of an otherwise healthy diet, there isn't much to suggest concern about consuming unprocessed red meat. While others are of the view that there does exist a risk and that limiting or even avoiding consumption is prudent. The crucial concept of replacement effects is discussed. Increasing red meat intake always means decreasing something else or increasing total energy intake. Therefore, interpreting evidence requires specifying the comparator food(s), the background dietary pattern, the dose, the cut (lean vs fatty), and how the meat is prepared. To discuss their interpretations of this contentious evidence base, Dr. Mario Kratz and Dr. Gil Carvalho join the podcast to go through the studies most directly related to these questions. Timestamps [06:20] Red meat's impact is debated [10:54] Mechanisms linking meat to diabetes [15:31] Cohort evidence on diabetes risk [24:43] Differences between cohorts and threshold effects [33:13] RCT evidence and substitution trials [45:49] Why comparator foods matter [50:43] RCT examples and mixed results [01:00:30] Is there cardiovascular risk beyond saturated fat? [01:08:10] Epidemiology patterns and dose thresholds [01:11:36] Personal recommendations and risk tolerance [01:16:19] Key ideas Related Resources Go to episode page (study links, guest bios, additional resources) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Mario's YouTube channel: Nourished By Science Gil's YouTube channel: Nutrition Made Simple!

This episode examines how exercise and nutrition interact to influence glycaemic control, with particular focus on the postprandial period (i.e., the hours after eating) and on "time-efficient" exercise strategies such as low-volume interval training. Dr. Jenna Gillen outlines the physiological basis for why muscle contraction can acutely reduce post-meal glucose excursions, why repeated sessions can accumulate into longer-term improvements in insulin sensitivity, and why the nutrition context (pre- and post-exercise feeding, carbohydrate availability, and energy balance) can meaningfully alter observed outcomes. A key translational thread is that many clinically relevant improvements may come from small, feasible doses of activity; especially post-meal walking and brief "exercise snacks" used to interrupt sedentary time. However, the discussion considers who these interventions matter for most (and least). Postprandial glucose rises are normal in healthy individuals, whereas reducing exaggerated excursions is most relevant for those with insulin resistance, prediabetes, or type 2 diabetes (T2D). Dr. Jenna Gillen is an Assistant Professor of Exercise Physiology in the Faculty of Kinesiology & Physical Education at the University of Toronto.  Timestamps [02:42] Dr. Gillen's research focus [04:11] Understanding glycemic control [10:07] Fasted vs. fed state exercise [11:10] Post-meal exercise benefits [20:10] Low volume interval training [26:27] Interval training and blood glucose [31:29] Energy balance and insulin sensitivity [36:32] Exercise and nutrition interactions [40:11] Practical exercise recommendations [43:56] Key ideas segment (Premium-only) Links Go to episode page (with links to papers) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course See Sigma's recommended resources

In clinical practice effective nutrition, exercise, and obesity care is rarely about identifying the single "best" plan on paper. Instead, sustainable change depends on behavioral psychology: understanding the person's context, motivation, barriers, and patterns, then co-designing practical steps that can actually be implemented in real life. David Creel PhD, RD is a clinical psychologist and registered dietitian working in weight management at the Cleveland Clinic. Dr. Creel discusses how clinicians can bridge the gap between "optimal recommendations" and what is most likely to create actual behaviour change. This includes a combination of using collaborative communication, self-monitoring, skill-building, relapse prevention planning, and a multidisciplinary framework. Behavioral and psychological factors shape food choices, physical activity, and adherence far more than knowing the newest guideline. In addition, the modern obesity treatment landscape (including GLP-1 receptor agonists) increases the need for structured behavior-change support: people may experience new hope and new fear (especially fear of weight regain), and the key clinical question becomes how to use these tools to build durable habits and reduce relapse risk over the long term. Timestamps [03:09] Start of interview [05:31] Challenges in nutrition and exercise recommendations [11:01] Behavior change in real-world practice [16:32] Self-monitoring and its importance [23:48] Non-scale victories and positive body image [25:58] Focusing on body capabilities over aesthetics [27:20] Integrating activity into lifestyle [30:30] Exercise snacking and practical tips [33:36] Impact of GLP-1 receptor agonists [38:24] Addressing fear of weight regain [41:24] Effective multidisciplinary obesity treatment Related Resources Go to episode page Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course LinkedIn: Dr. David Creel Danny Lennon X/Twitter: @drdavidcreel @NutritionDanny

Omega-3 fatty acids (particularly EPA and DHA) have a long history in nutrition and cardiovascular medicine, yet the clinical trial literature is often perceived as inconsistent. This episode examines why some randomized trials show clear benefit while others show null or mixed findings, and how differences in trial design, dose, population risk, and outcome selection can materially change what we observe. A key theme is separating (1) the persistent cultural narratives around omega-3s (including origin stories that do not hold up well to modern evidence) from (2) the more precise, mechanistic and clinical questions about where supplemental EPA/DHA may reduce cardiovascular risk. The discussion focuses heavily on understanding heterogeneity: why "omega-3 supplementation" is not a single, uniform exposure, and why subgroup patterns (e.g., secondary prevention, higher baseline triglycerides, and higher doses) may explain much of the apparent conflict in the evidence. Note: This discussion is taken from a previous episode of the podcast. The audio has been remastered and improved, and now study notes and full transcript are available. Timestamps [04:10] Omega-3 historical context and Inuit studies [08:38] Mechanisms of omega-3 benefits [12:49] VITAL and ASCEND trials analysis [23:41] GISSI-Prevenzione trial insights [26:44] REDUCE-IT trial and residual risk [32:19] Significance of baseline triglycerides [37:57] 2018 Cochrane review [46:02] Hu et al. meta-analysis [01:00:27] Practical takeaways for omega-3 supplementation [01:03:55] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to mentioned studies) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Alan Flanagan's Alinea Nutrition Education Hub

Conversations about brain health have been dominated by a competing mix of fatalism and over-promising, with aging framed as inevitable decline and "brain optimisation" sold through weak evidence. So how should we think about cognition across the lifespan? In this episode, we explore the idea that neuroplasticity does not disappear in adulthood, but instead continues to respond, for better or worse, to repeated behaviours and exposures. Much of what is labelled age-related cognitive decline may in fact reflect an accumulation of modifiable risk factors. We also dig into how to critically evaluate brain-health claims and how lifestyle pillars such as exercise, sleep, diet, stress reduction and cognitive training fit into a coherent framework. The discussion extends to emerging multimodal intervention programs, their promising signals and their clear limitations, and to a broader, multifactorial view of Alzheimer's disease that moves beyond a narrow amyloid-centric model. Finally, we examine the role of genetics, including ApoE4, and why genetic risk does not equate to biological destiny, even later in life. Dr. Majid Fotuhi is a neurologist and an adjunct professor at the Johns Hopkins Mind/Brain Institute. He earned his medical degree from Harvard Medical School and completed a Ph.D. in neuroscience at Johns Hopkins University. That was followed by internship and neurology residency at Johns Hopkins Hospital. Timestamps [03:41] Understanding neuroplasticity [05:22] Risk factors for cognitive decline [07:07] Evidence-based interventions for brain health [09:37] The five pillars of brain health [10:42] Dr. Fotuhi's multimodal program [19:09] Measuring cognitive function [24:43] The role of amyloid and tau in Alzheimer's [27:53] Genetics and lifestyle in brain health [30:03] Debunking myths and overhyped claims [36:08] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to studies mentioned) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Dr. Fotuhi's book: The Invincible Brain